anti-IGF-BP7 antibody product blog
Tags: Antibody; Polyclonal Antibody; IGF-BP7; anti-IGF-BP7 antibody;
The IGF-BP7 igfbp7 (Catalog #MBS695287) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Biotinylated Anti-hIGF-BP7 reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s IGF-BP7 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).Direct Detection: To detect hIGF-BP7 by direct ELISA (using 100 mul/well antibody solution) a concentration of 0.25 - 1.0 mug/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with compatible secondary reagents, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIGF-BP7.
Sandwich ELISA: To detect hIGF-BP7 by sandwich ELISA (using 100 mul/well antibody solution) a concentration of 0.25 - 1.0 mug/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with Polyclonal Anti-Human IGF-BP7 as a capture antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hIGF-BP7.
Western Blot: To detect hIGF-BP7 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIGF-BP7 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. Researchers should empirically determine the suitability of the IGF-BP7 igfbp7 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The IGF-BP7 igfbp7 product has the following accession number(s) (GI #23396609) (NCBI Accession #Q16270.1) (Uniprot Accession #Q16270). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hIGF-BP7. Anti-Human IGF-BP7 specific antibody was purified by affinity chromatography and then biotinylated.
Immunogen: Recombinant Human IGF-BP7. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IGF-BP7 are readily searchable from our website. Different antibodies against the same target such as IGF-BP7 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. IGF-BP7 also interacts with the following gene(s): CTGF, IGF1, IGF2, LIF, TP53, VEGFA. Adenocarcinoma, Breast Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Cardiovascular Diseases, Leukemia, Liver Diseases, Liver Neoplasms, Lung Neoplasms, Neoplasms, Experimental are some of the diseases may be linked to Biotinylated Anti-hIGF-BP7. Blood, Brain, Embryonic Tissue, Heart, Kidney, Liver, Lung, Muscle, Skin, Vascular tissues are correlated with this protein.